NCT03746262View on ClinicalTrials.gov

Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

May 13, 2016

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions

Non Small Cell Lung Cancer

Trial Locations (1)

27157

Wake Forest Baptist Medical Center, Winston-Salem

Sponsors

Collaborators (1)

Guardant Health, Inc.

All Listed Sponsors

collaborator

Guardant Health, Inc.

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER